title: [Course and regression of HELLP syndrome].
abstract: The authors reported the outcome of a retrospective study of patients with HELLP syndrome to verify whether this pathology is a clinical entity with models of evolution, regression and well defined treatment. A total of 20 individual cases were reported at the Division of Obstetrics and Gynecology at the G. Gaslini Institute during the period from January 1990 to September 1995. All cases showed the normalisation of the various clinical and hematochemical parameters within a maximum of 8 days after birth. The rapid diagnosis, the immediate extraction of the fetus and appropriate medical treatment led to the prompt resolution of this severe pathology without the need for demolitive surgery frequently used in the past.
authors.affiliation: Divisione di Ostetricia e Ginecologia, Istituto G. Gaslini, Genova.
authors.forename: E
authors.initials: E
authors.lastname: Figini
authors.forename: G
authors.initials: G
authors.lastname: Za
authors.forename: M
authors.initials: M
authors.lastname: Squarcina
authors.forename: M
authors.initials: M
authors.lastname: Marras
authors.forename: U
authors.initials: U
authors.lastname: Passamonti
authors.forename: G
authors.initials: G
authors.lastname: Bocchino
authors.forename: P G
authors.initials: PG
authors.lastname: Mori
authors.forename: A
authors.initials: A
authors.lastname: Gandolfo
authors.forename: M L
authors.initials: ML
authors.lastname: Massone
authors.forename: E
authors.initials: E
authors.lastname: Santi
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002585:Cesarean Section; D005260:Female; D017359:HELLP Syndrome / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D007231:Infant, Newborn; D008423:Maternal Age; D010298:Parity; D010952:Plasma Substitutes / Q000008:administration & dosage; D010956:Plasmapheresis; D011247:Pregnancy; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D000927:Anticonvulsants; D000959:Antihypertensive Agents; D010952:Plasma Substitutes